Abstract
The efficacy of cisapride as a treatment for chronic constipation in children with severe brain damage was studied in 20 children. Each subject was randomly assigned to double-blind treatment with either cisapride (N=10) or placebo (N=10) for 12 weeks. Stool habits, total gastrointestinal transit time, colonic segmental transit times, and anorectal motility were evaluated in all children before and at the end of the treatment period. Although cisapride significantly (P<0.05) increased stool frequency from baseline to week 12 and no significant change was documented in the placebo group, the mean change in stool frequency per week from baseline to 12 week was not significantly different between the two treatment groups. The use of laxatives or suppositories was significantly (P<0.05) decreased by cisapride, but remained unchanged in the placebo group. Furthermore, cisapride significantly (P<0.05) reduced rectal compliance but had no effect on total gastrointestinal transit time and colonic segmental transit times. In summary, in neurologically impaired children with chronic constipation, cisapride increased bowel frequency but did not alter the delay in total and segmental gastrointestinal transit times.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Johanson JF, Sonnenberg A, Koch TR, Mccarty DJ: Association of constipation with neurologic diseases. Dig Dis Sci 37:179–186, 1992
Burkitt DP, Walker ARP, Painter NS: Dietary fiber and disease. JAMA 229:1068–1074, 1974
Bingham SA, Cummings JH: Effects of exercise and physical fitness on large intestinal function. Gastroenterology 97:1389–1399, 1989
Staiano A, Del Giudice E: Anorectal manometry and colonic transit in children with brain damage. Pediatrics 94:169–173, 1994
Staiano A, Cucchiara S, Andreotti MR, Minella R, Manzi G: Effect of cisapride on chronic idiopathic constipation in children. Dig Dis Sci 36:733–736, 1991
Diagnostic & Statistical Manual of Mental Disorders, 3rd ed, rev. American Psychiatric Association, Washington, DC, 1987
Menardo G, Bausano G, Corazziari E, Fazio A, Marangi A, Genta V, Marenco G: Large-bowel transit in paraplegic patients. Dis Colon Rectum 30:924–928, 1987
Corazziari E, Dani S, Pozzessere C, Anzini F, Torsoli A: Colonic segmental transit times in non-organic constipation. Rend R Gastroenterol 7:67–69, 1975
Krevsky B, Malmud LS, Maurer AH, et al: The effect of oral cisapride on colonic transit. Aliment Pharmacol Ther 1:293–304, 1987
Edwards CA, Holden S, Brown C, Read NW: Effect of cisapride on the gastrointestinal transit of a solid meal in normal human subjects. Gut 28:13–16, 1987
Corazziari E, Cucchiara S, Staiano A, et al: Gastrointestinal transit time, frequency of defecation, and anorectal manometry in healthy and constipated children. J Pediatr 103:379–382, 1985
Di Lorenzo C, Flores AF, Reddy SN, Hyman PE: Use of colonic manometry to differentiate causes of intractable constipation in children. J Pediatr 120:690–695, 1992
Verlinden M: A role for gastrointestinal prokinetic agent in the treatment of reflux esophagitis? Aliment Pharmacol Ther 3:113–131, 1989
Di Lorenzo C, Reddy SN, Villanueva-Meyer J, Mena I, Martin S, Hyman PE: Cisapride in children with chronic intestinal pseudoobstruction. Gastroenterology 101:1564–1570, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Staiano, A., Del Giudice, E., Simeone, D. et al. Cisapride in neurologically impaired children with chronic constipation. Digest Dis Sci 41, 870–874 (1996). https://doi.org/10.1007/BF02091525
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02091525